Purdue Pharma L.P., headquartered in Stamford, CT, specializes in the development and manufacturing of pharmaceutical formulations with a focus on tamper-resistant technologies. The company is known for its innovative approaches to opioid treatments and is actively engaged in research addressing sleep disorders and various cancers, including lymphoma and triple-negative breast cancer (TNBC). Purdue Pharma is committed to advancing therapeutic solutions that meet critical medical needs while prioritizing patient safety.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

547 Patents

#8 in Stamford, CT

#31 in Connecticut

#893 in US

#1,775 in the World

Stamford, CT, United States of America

Purdue Pharma L.p.

Forward Citations = 9,757

196 inventors:

Benjamin Oshlack (118 out of 157 patents)

Laykea Tafesse (84 out of 91 patents)

Curtis Wright (74 out of 86 patents)

4. Donald Kyle (66 out of 341 patents)

5. Haiyong Hugh Huang (62 out of 63 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Purdue Pharma L.p.. Retrieved from https://idiyas.com/company/purdue-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

86 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]